2841
Global X China MedTech ETF
NAV as of
4 Week: 49.36 - 50.84
52 Week: 48.68 - 51.90
Latest Closing Price
50.28
Premium / Discount
0.89
Expense Ratio
0.68%
Investment Objective
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China MedTech Index (the “Index”).
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | 0.00 | 0.00 | 0.00 |
| 1 Day | -1.39 | 0.00 | 0.00 |
| 1 Week | -0.80 | 2.74 | -0.29 |
| 1 Month | -1.31 | 5.10 | -0.26 |
| 3 Months | 0.00 | 0.00 | 0.00 |
| 6 Months | 0.00 | 0.00 | 0.00 |
| 1 Year | 0.00 | 0.00 | 0.00 |
| 2 Years | 0.00 | 0.00 | 0.00 |
| 3 Years | 0.00 | 0.00 | 0.00 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| N.A | ||
Portfolio Data
Total Number of Holdings: 31
Number of Bond Holdings: 0
Number of Equity Holdings: 30
Total Market Value: 29,875,093
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Aier Eye Hospital Group Co Ltd Class A | 9.2896 | 154,440 | 0 | 2,775,287 |
| 2 | Shenzhen Mindray Bio-Medical Electronics Co Ltd Cl | 8.8506 | 9,800 | 0 | 2,644,138 |
| 3 | Imeik Technology Development Co Ltd Class A | 8.4912 | 6,500 | 0 | 2,536,755 |
| 4 | JD Health International Inc | 7.4149 | 58,651 | 0 | 2,215,200 |
| 5 | Alibaba Health Information Technology Ltd | 6.0451 | 397,816 | 0 | 1,805,982 |
| 6 | Shenzhen New Industries Biomedical Engineering Co | 4.9753 | 23,400 | 0 | 1,486,368 |
| 7 | Genscript Biotech Corp Class H | 4.7637 | 74,083 | 0 | 1,423,148 |
| 8 | Jiangsu Yuyue Medical Equipment And Supply Co Ltd | 3.4930 | 30,300 | 0 | 1,043,532 |
| 9 | Shandong Weigao Group Medical Polymer Co Ltd Class | 3.0547 | 142,585 | 0 | 912,586 |
| 10 | Lepu Medical Technology (Beijing) Co Ltd Class A | 2.9643 | 53,900 | 0 | 885,577 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 18.14 |
| Large | 47.25 |
| Medium | 29.51 |
| Small | 4.76 |
| Micro | 0.00 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
28.9462
Price/Book*
2.8047
Price/Sales*
4.0416
Price/Cash Flow*
20.1924
Dividend Yield*
2.0189
Growth Measures
Long-Term Earnings
24.0946
Historical Earnings
32.8472
Sales Growth
23.5196
Cash-Flow Growth
-7.4274
Book-Value Growth
20.4799
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
